Further studies on the function of Ypk9p/ATP13A2, mainly in terms of identification of the cellular mechanisms of toxicity and of new predisposition factors to early Parkinsonism, would definitely help define the molecular basis of Kufor–Rakeb syndrome and lead to the development of therapeutic alternatives. This evidence concerns the gene ATP13A2 and Parkinson disease.